DS Healthcare Group Files Patent for Prescription Hair Loss Treatment

DS Healthcare Group Files Patent for Prescription Hair Loss Treatment

Company's first move into pursuing prescription hair loss treatment market

Pompano Beach, Oct. 29, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc.
(NASDAQ:DSKX), a leading developer of personal care products, today announced
it has filed a patent application titled, "Compositions and Methods for
Treatment of Hair Loss," with the United Stated Patent and Trademark Office.
The patent application addresses DS Healthcare's proprietary formulations that
stimulate hair growth and reduce hair loss in men and women through treatments
delivered topically.

"We believe there is tremendous unmet demand for an effective prescription
grade hair loss treatment. Although a few other prescription products have
been launched for this indication in the past decades, they have either been
less effective than users would prefer, or have been coupled been side effects
that most users have found to be unacceptable," stated DS Healthcare President
and CEO Daniel Khesin. "Having already generated millions of dollars providing
over-the-counter shampoos and other topical hair growth products, we know this
market and we believe our proprietary prescription-grade formulation holds
promise for the millions of people looking to preserve their hair growth."

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for
topical, and nutritional therapies. It markets through online and specialty
retailers, distributors, cosmetics wholesalers, and salons. Its brands include
DS Laboratories (www.DSLaboratories.com), Sigma Skin (www.SigmaSkin.com),
Polaris Research Laboratories (www.PolarisReserachLabs.com) and The Pure Guild
(www.ThePureGuild.com).

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press
release are forward-looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or strategies, and
are generally preceded by words such as "future," "plan" or "planned,"
"expects," or "projected." These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many of which
are beyond the company's control that may cause actual results to differ
materially from stated expectations. These risk factors include, among others,
limited operating history, difficulty in developing and marketing products,
intense competition, and additional risks factors as discussed in reports
filed by the company with the Securities and Exchange Commission, which are
available at http://www.sec.gov.

CONTACT: Contact:
         Laurel Moody
         Corporate Profile
         1.646.810.0608

DS Healthcare Group,Inc.
 
Press spacebar to pause and continue. Press esc to stop.